These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2907738

  • 21. Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
    Vo D, Wolowyk MW, Knaus EE.
    Drug Des Discov; 1993 Jun; 10(2):89-99. PubMed ID: 8104518
    [Abstract] [Full Text] [Related]

  • 22. Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
    Meyer RF, Stratton CD, Hastings SG, Corey RM.
    J Med Chem; 1973 Oct; 16(10):113-6. PubMed ID: 4147942
    [No Abstract] [Full Text] [Related]

  • 23. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.
    Schliep HJ, Harting J.
    J Cardiovasc Pharmacol; 1984 Oct; 6(6):1156-60. PubMed ID: 6084774
    [Abstract] [Full Text] [Related]

  • 24. A new beta-adrenoceptor blocking agent derived from dehydrozingerone.
    Wu BN, Yang CR, Yang JM, Chen IJ.
    Gen Pharmacol; 1994 Jul; 25(4):651-9. PubMed ID: 7958725
    [Abstract] [Full Text] [Related]

  • 25. beta-adrenoreceptor blocking and antihypertensive activity of PP-24, a newly synthesized aryloxypropanolamine derivative.
    Nikam AP, Bodhankar SL, Piplani P, Bansal J, Thakurdesai PA.
    J Pharm Pharmacol; 2008 Nov; 60(11):1501-6. PubMed ID: 18957171
    [Abstract] [Full Text] [Related]

  • 26. [On the pharmacology of the beta-receptor blocker penbutolol (author's transl)].
    Kaiser J, Härtfelder G, Lindner E, Schölkens B.
    Arzneimittelforschung; 1980 Nov; 30(3):420-7. PubMed ID: 6992788
    [Abstract] [Full Text] [Related]

  • 27. New isoxazole derivatives with a potent and selective beta 2-adrenergic activity.
    Chiarino D, Fantucci M, Carenzi A, Della Bella D, Frigeni V, Sala R.
    Farmaco Sci; 1986 Jun; 41(6):440-53. PubMed ID: 2874994
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of beta-adrenolytic properties of N,N'-bis-(3-(p-methoxyphenoxy)-2-hydroxypropyl)-ethylenediamine and its N,N'-dimethyl derivative.
    Robak J, Grodzińska L.
    Pol J Pharmacol Pharm; 1973 Jun; 25(3):253-7. PubMed ID: 4150018
    [No Abstract] [Full Text] [Related]

  • 29. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II).
    Khouili M, Guillaumet G, Coudert G, Pujol MD.
    Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140
    [Abstract] [Full Text] [Related]

  • 30. Synthesis and beta-adrenergic antagonist activity of novel (3-oxazolinyl-1,4-dihydropyridyl) propanolamines.
    Vo D, Wolowyk MW, Knaus EE.
    Drug Des Discov; 1992 Jul; 8(4):265-72. PubMed ID: 1359908
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA, Stokes GS, Gain JM.
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [Abstract] [Full Text] [Related]

  • 32. [Synthesis of 2-{3-[4-(4-fluorophenyl)-1-piperazinyl]-2-hydroxy-propoxy}-phenylcarbamic acid alkylesters and in vitro evaluation of their beta-antiadrenergic and vasodilatative activities].
    Gonec T, Racanská E, Csöllei J.
    Ceska Slov Farm; 2008 Jun; 57(3):115-8. PubMed ID: 18683428
    [Abstract] [Full Text] [Related]

  • 33. Comparative study of beta-adrenoceptor blocking efficacy of two formulations of esmolol in vivo and in vitro.
    Tripathi CB, Bhattacharya P, Bhatt JD, Hemavathi KG.
    Indian J Physiol Pharmacol; 1999 Apr; 43(2):255-8. PubMed ID: 10365322
    [Abstract] [Full Text] [Related]

  • 34. Nondepressant beta-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanols.
    Condon ME, Cimarusti CM, Fox R, Narayanan VL, Reid J, Sundeen JE, Hauck FP.
    J Med Chem; 1978 Sep; 21(9):913-22. PubMed ID: 31485
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Correlation between the potency of seven potential beta-adrenoceptor blocking drugs and propranolol to decrease heart rate in reserpinized rats and to perturb liposomes prepared from platelet lipids.
    Ondriasova E, Stasko A, Racanská E, Svec P, Ondrias K.
    Pharmazie; 1991 Dec; 46(12):889-90. PubMed ID: 1687834
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
    Nakagawa K, Murakami N, Yoshizaki S, Tominaga M, Mori H.
    J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
    [No Abstract] [Full Text] [Related]

  • 39. Beta-blocking activity of PP-34, a newly synthesized aryloxypropanolamine derivative, and its cardioprotective effect against ischaemia/reperfusion injury in laboratory animals.
    Bhatt LK, Nandakumar K, Bodhankar SL, Bansal J, Piplani P.
    J Pharm Pharmacol; 2007 Mar; 59(3):429-36. PubMed ID: 17331347
    [Abstract] [Full Text] [Related]

  • 40. Synthesis and beta-adrenergic activity of new completely aliphatic 3-(methyleneaminoxy)propanolamine derivatives.
    Balsamo A, Gentili D, Lapucci A, Macchia M, Martinelli A, Orlandini E, Ferni G, Pinza M.
    Farmaco; 1994 Dec; 49(12):759-66. PubMed ID: 7893332
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.